A detailed history of Envestnet Asset Management Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 98,740 shares of BIO stock, worth $32.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
98,740
Previous 109,051 9.46%
Holding current value
$32.7 Million
Previous $29.8 Million 10.93%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$263.97 - $344.64 $2.72 Million - $3.55 Million
-10,311 Reduced 9.46%
98,740 $33 Million
Q2 2024

Aug 08, 2024

BUY
$268.26 - $339.48 $2.46 Million - $3.12 Million
9,185 Added 9.2%
109,051 $29.8 Million
Q1 2024

May 13, 2024

SELL
$304.11 - $351.99 $642,280 - $743,402
-2,112 Reduced 2.07%
99,866 $34.5 Million
Q4 2023

Feb 13, 2024

SELL
$269.37 - $365.04 $18.4 Million - $24.9 Million
-68,251 Reduced 40.09%
101,978 $32.9 Million
Q3 2023

Nov 13, 2023

BUY
$350.25 - $422.63 $19.3 Million - $23.3 Million
55,233 Added 48.03%
170,229 $61 Million
Q2 2023

Aug 04, 2023

BUY
$359.49 - $486.4 $2.07 Million - $2.8 Million
5,761 Added 5.27%
114,996 $43.6 Million
Q1 2023

May 11, 2023

BUY
$418.69 - $503.0 $2.19 Million - $2.63 Million
5,223 Added 5.02%
109,235 $52.3 Million
Q4 2022

Feb 07, 2023

BUY
$351.71 - $456.01 $4.59 Million - $5.96 Million
13,062 Added 14.36%
104,012 $43.8 Million
Q3 2022

Nov 10, 2022

BUY
$412.59 - $563.26 $3.94 Million - $5.38 Million
9,551 Added 11.73%
90,950 $37.9 Million
Q2 2022

Aug 03, 2022

BUY
$463.67 - $597.16 $3.72 Million - $4.79 Million
8,023 Added 10.93%
81,399 $40.3 Million
Q1 2022

May 04, 2022

BUY
$524.57 - $735.42 $2.64 Million - $3.7 Million
5,036 Added 7.37%
73,376 $41.3 Million
Q4 2021

Feb 04, 2022

BUY
$708.84 - $794.68 $5.58 Million - $6.26 Million
7,878 Added 13.03%
68,340 $51.6 Million
Q3 2021

Oct 07, 2021

BUY
$657.71 - $825.77 $2.62 Million - $3.29 Million
3,990 Added 7.07%
60,462 $45.1 Million
Q2 2021

Aug 04, 2021

BUY
$576.64 - $649.04 $2.65 Million - $2.98 Million
4,595 Added 8.86%
56,472 $36.4 Million
Q1 2021

May 04, 2021

BUY
$547.01 - $662.35 $4.16 Million - $5.04 Million
7,610 Added 17.19%
51,877 $29.6 Million
Q4 2020

Feb 02, 2021

BUY
$510.68 - $643.45 $184,866 - $232,928
362 Added 0.82%
44,267 $25.8 Million
Q3 2020

Oct 09, 2020

BUY
$454.43 - $535.6 $487,148 - $574,163
1,072 Added 2.5%
43,905 $22.6 Million
Q2 2020

Jul 08, 2020

BUY
$334.87 - $493.06 $2.15 Million - $3.16 Million
6,414 Added 17.61%
42,833 $19.3 Million
Q1 2020

Apr 23, 2020

BUY
$320.01 - $409.07 $1.48 Million - $1.89 Million
4,614 Added 14.51%
36,419 $12.8 Million
Q4 2019

Feb 11, 2020

BUY
$319.73 - $374.2 $3.86 Million - $4.52 Million
12,067 Added 61.14%
31,805 $11.8 Million
Q3 2019

Oct 17, 2019

BUY
$304.55 - $345.24 $570,117 - $646,289
1,872 Added 10.48%
19,738 $6.57 Million
Q2 2019

Aug 02, 2019

BUY
$286.93 - $312.59 $550,905 - $600,172
1,920 Added 12.04%
17,866 $5.59 Million
Q1 2019

May 10, 2019

BUY
$224.3 - $317.41 $651,591 - $922,076
2,905 Added 22.28%
15,946 $4.87 Million
Q4 2018

Feb 13, 2019

BUY
$220.1 - $309.0 $2.87 Million - $4.03 Million
13,041 New
13,041 $3.03 Million
Q3 2018

Nov 14, 2018

SELL
$289.28 - $326.15 $670,261 - $755,689
-2,317 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$244.1 - $303.88 $1,708 - $2,127
-7 Reduced 0.3%
2,317 $668,000
Q1 2018

May 09, 2018

SELL
$233.97 - $274.11 $630,081 - $738,178
-2,693 Reduced 53.68%
2,324 $581,000
Q4 2017

Feb 20, 2018

SELL
$216.94 - $271.3 $6,508 - $8,139
-30 Reduced 0.59%
5,017 $1.2 Million
Q3 2017

Nov 13, 2017

SELL
$212.27 - $242.28 $25,260 - $28,831
-119 Reduced 2.3%
5,047 $1.12 Million
Q2 2017

Aug 14, 2017

BUY
N/A
5,166
5,166 $1.17 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.15B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.